Pharma Stocks

India-EU sign ‘mother of all deals’: Stocks to buy, winners and losers

India has sealed a free trade agreement (FTA) with the European Union—hailed by Prime Minister Narendra Modi as the “mother…

Read More »

13 stocks to watch today: PVR Inox, Marico, Sun Pharma, Cipla, ABB India & others

Stocks may stay active as PVR Inox exits 4700BC, Sun Pharma and Cipla recall US products, HCL Tech acquires Finergic,…

Read More »

Kodak adds four regulated pharma products for labs

Key Terms cdmos technical Contract Development and Manufacturing Organizations (CDMOs) are independent companies that help drug and biologic developers by…

Read More »

How Boehringer Ingelheim Oncology Collaboration Could Shape Jazz Pharmaceuticals’ (JAZZ) Dual HER2 Strategy

In January 2026, Boehringer Ingelheim announced a clinical collaboration with Jazz Pharmaceuticals to test a combination of zongertinib and zanidatamab…

Read More »

How Investors Are Reacting To ORIC Pharmaceuticals (ORIC) Big-Pharma Partnerships And Cancer Resistance Pipeline

In recent weeks, Oric Pharmaceuticals has drawn increased attention as investors focused on its cancer resistance therapy pipeline, including Phase…

Read More »

Pinning Down InnoCare Pharma Limited’s (HKG:9969) P/S Is Difficult Right Now

There wouldn’t be many who think InnoCare Pharma Limited’s (HKG:9969) price-to-sales (or “P/S”) ratio of 12.5x is worth a mention…

Read More »

Will Royalty Pharma’s (RPRX) Dividend Hike and Guidance Reset Change Its Efficiency and Growth Narrative

Royalty Pharma, which acquires rights to portions of biopharmaceutical sales instead of conducting its own research, recently raised its dividend…

Read More »

Boring Pharma Or Sneaky Millionaire Maker?

Everyone’s chasing hyped-up AI stocks, but Gilead Sciences just quietly moved. Is this pharma giant a sleeper win or a…

Read More »

Takeda Pharmaceutical (TSE:4502) Valuation Check After Launch Of GAMMAGARD LIQUID ERC In The United States

Takeda Pharmaceutical (TSE:4502) has drawn fresh attention after launching GAMMAGARD LIQUID ERC in the U.S., a ready to use, low…

Read More »

Assessing Zealand Pharma (CPSE:ZEAL) Valuation After Prolonged Share Price Weakness

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.…

Read More »